Translating Evidence to Practice to Improve Outcomes in Relapsed/Refractory Diffuse Large B-Cell Lymphoma - Episode 10

Future of R/R DLBCL

, , , ,

A panel of experts discuss the future of R/R DLBCL treatment and review some recent data from the 2022 ASH meeting.

Current Time 0:00
Duration 0:00
Loaded: 0%
Stream Type LIVE
Remaining Time 0:00
 
1x
  • Chapters
  • descriptions off, selected
  • captions off, selected
    EP. 1: Front-Line Treatment Options for Patients with DLBCL
    EP. 2: An Overview of R/R DLBCL
    EP. 3: Treatment Options for Patients with R/R DLBCL
    EP. 4: L-MIND: Review of Long-Term Analyses Data
    EP. 5: Role of CAR T-cell Therapy in Patients with R/R DLBCL
    EP. 6: Eligibility Criteria for CAR T-Cell Therapy in R/R DLBCL
    EP. 7: ZUMA-7: Clinical Implications
    EP. 8: Sequencing Therapies in Patients with R/R DLBCL
    EP. 9: Potential Role of CAR T-cell Therapy in the Front-line Setting for Patients with R/R DLBCL
    Now Viewing
    EP. 10: Future of R/R DLBCL
    x